Skip to main content

#

Melb-p3 cell line

Melb-p3 cell line

Organism: Mouse

Tissue: Skin

Disease: Non-cancer

Model: Immortalised non-cancerous cell lines

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Elena Sviderskaya

Institute: St. George's University London

Primary Citation: Sviderskaya EV, et al. J Invest Dermatol. 1997 Jan;108(1):30-4. PMID: 8980282

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Melb-p3 cell line
  • Cancer: N/A
  • Research fields: Tissue-specific biology
  • Organism: Mouse
  • Gender: Unspecified
  • Tissue: Skin
  • Disease: Non-cancer
  • Morphology: Small, oval-fusiform
  • Growth properties: Adherent
  • Model: Immortalised non-cancerous cell lines
  • Crispr: No
  • Conditional: No
  • Description: The melb-p3 and melb-4 lines are immortal melanoblast cell lines derived from Oca2p-cp/Oca2p-25H CH3 mice. These melanoblasts can grow in melanocyte growth medium without differentiating to melanocytes. This melanoblast line may be useful for developmental studies and, as melanoblasts display mechanisms similar to tumour cells (migration to and invasion of the epidermis) they may be a useful tool in studies of melanoma development. Melanocyte lines (melan-p1 and melan-p2) derived from Oca2p-cp/Oca2p-25H CH3 mice are also available from Cancer Tools.
  • Application: Melanocyte cell biology
  • Biosafety level: BSL1

Applications

  • Application: Melanocyte cell biology

Handling

  • Growth medium: RPMI + FBS (10%) + TPA (200 nM) + CT (200 pM) + 2ME (100 µM)
  • Storage conditions: liquid N2

References

  • Sviderskaya EV, et al. J Invest Dermatol. 1997 Jan
  • 108(1):30-4. PMID: 8980283

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.